| 1 |
31159802 | The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis. | 2019 Jun 3 |
3 |
| 2 |
28688245 | The timing of administration of exogenous glucocorticoid affects 24hour growth hormone secretion in children. | 2017 Aug |
1 |
| 3 |
28945869 | Effects of Prednisolone on Serum and Tissue Fluid IGF-I Receptor Activation and Post-Receptor Signaling in Humans. | 2017 Nov 1 |
3 |
| 4 |
23038624 | Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1. | 2013 Jan |
2 |
| 5 |
16079165 | Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. | 2006 Mar |
2 |
| 6 |
11922563 | Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. | 2002 Mar |
3 |
| 7 |
11509866 | No influence of prednisolone on IGFBP-3 proteolysis in healthy young men. | 2001 |
1 |
| 8 |
7545698 | Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. | 1995 Sep |
1 |
| 9 |
2278223 | Insulin-like growth factor-I in prednisolone-treated children. | 1990 Jan-Feb |
2 |